Lockheed Martin Reports Second Quarter 2026 Financial Results

Lockheed Martin reported Q2 sales of $20.1B (+11% YoY) and net earnings of $1.8B ($7.94/share) versus $342M ($1.46/share) a year ago, alongside free cash flow of $2.9B (vs. -$150M). The company set a record backlog of $230B and signed a $35B multi-year THAAD contract with the Missile Defense Agency. It raised full-year guidance to anticipate ~8% accelerated YoY sales growth, ~28% higher segment operating profit, and free cash flow projected to exceed $7B—driving a favorable read-through for defense demand and cash generation.

Analysis

The real signal here is not the headline print; it is that defense spending is migrating toward munitions and air/missile defense, where pricing power and backlog visibility are structurally better than on classic airframe programs. That mix shift should support LMT’s multiple relative to the prime-defense group if it persists for 2-4 quarters, because the market tends to pay for funded backlog and repeatable production ramps more than for one-time program recoveries.

Near term, the stock should be helped over days to weeks by guidance confidence, but the 1-3 month path depends on whether order flow converts into funded work without schedule or supplier slippage. Watch working capital: the cash surge is not fully “quality” if contract assets and inventories keep rising faster than billings; that can make FCF look better than underlying earnings power for a quarter or two.

The contrarian view is that investors may be underestimating how much of the earnings step-up is a normalization from prior charges versus a permanent margin re-rate. The cleaner second-order winners are not the obvious platform peers but select defense suppliers and the GM Defense partnership if it turns into real production volume; however, absent disclosed economics, that remains an option on future awards, not a current P&L driver. Falsifiers are simple: a cut to 2026 FCF, another program charge in Aeronautics/RMS, or evidence that missile-defense ramps are slowing despite the backlog.

Key Decisions for Investors

• Add LMT on any post-earnings consolidation; horizon 1-3 months. Expect the market to reward backlog quality and raised free-cash-flow guidance with modest multiple expansion. Falsify if 2026 FCF guidance slips below $7.0B or if another program-loss headline emerges.
• Pair trade: long LMT / short NOC for 1-3 months. Thesis: LMT has cleaner near-term backlog conversion and better exposure to interceptor/munitions ramps, while NOC remains more sensitive to program-execution noise. Cover if NOC wins a large funded award or LMT issues execution warnings.
• Buy a 3-6 month LMT call spread struck ~5%-15% above spot to express upside from backlog monetization while limiting downside to budget/shutdown risk. Take profits if implied vol compresses or the stock rallies into the upper end of the new guidance narrative.
• Set a watch item on GM rather than a full position: if management later quantifies defense-JV backlog or margin accretion, revisit a small long. Until then, it is an embedded call option, not a core thesis.